Trial Profile
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary) ; Temozolomide
- Indications Glioma
- Focus Pharmacokinetics
- 16 Nov 2018 Status changed from recruiting to completed.
- 24 Nov 2015 Planned primary completion date changed from 1 Feb 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov.
- 26 Mar 2015 New trial record